Malignant Mesothelioma Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Global Malignant Mesothelioma Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2026 – 2033, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Product Adoption Analysis
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Malignant Mesothelioma Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026–2033
   3. Global Malignant Mesothelioma Market Outlook: Drug Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Type, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
         1. Pemetrexed
         2. Cisplatin
         3. Carboplatin
         4. Gemcitabine
         5. Vinorelbine
         6. Others
      4. Market Attractiveness Analysis: Drug Type
   4. Global Malignant Mesothelioma Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
         1. Diagnostics
         2. Drug Discovery and Development
         3. Oncology
         4. Immunology
         5. Others
      4. Market Attractiveness Analysis: Route of Administration
   5. Global Malignant Mesothelioma Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
         1. Biopharmaceutical & Biotechnology Companies
         2. Academic Institutes & Research Laboratories
         3. Hospitals
         4. Contract Research Organizations
         5. Others
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Malignant Mesothelioma Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 – 2025
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Malignant Mesothelioma Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Type
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
      1. Pemetrexed
      2. Cisplatin
      3. Carboplatin
      4. Gemcitabine
      5. Vinorelbine
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Parenteral
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Oncology Centers
   7. Market Attractiveness Analysis
7. Europe Malignant Mesothelioma Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Type
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
      1. Pemetrexed
      2. Cisplatin
      3. Carboplatin
      4. Gemcitabine
      5. Vinorelbine
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Parenteral
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Oncology Centers
   7. Market Attractiveness Analysis
8. East Asia Malignant Mesothelioma Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Type
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
      1. Pemetrexed
      2. Cisplatin
      3. Carboplatin
      4. Gemcitabine
      5. Vinorelbine
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Parenteral
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Oncology Centers
   7. Market Attractiveness Analysis
9. South Asia & Oceania Malignant Mesothelioma Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Type
      3. By Route of Administration
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
      1. Pemetrexed
      2. Cisplatin
      3. Carboplatin
      4. Gemcitabine
      5. Vinorelbine
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Parenteral
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Oncology Centers
   7. Market Attractiveness Analysis
10. Latin America Malignant Mesothelioma Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
       1. By Country
       2. By Drug Type
       3. By Route of Administration
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
       1. Pemetrexed
       2. Cisplatin
       3. Carboplatin
       4. Gemcitabine
       5. Vinorelbine
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
       1. Oral
       2. Parenteral
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Oncology Centers
    7. Market Attractiveness Analysis
11. Middle East & Africa Malignant Mesothelioma Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
       1. By Country
       2. By Drug Type
       3. By Route of Administration
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2026 – 2033
       1. Pemetrexed
       2. Cisplatin
       3. Carboplatin
       4. Gemcitabine
       5. Vinorelbine
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 – 2033
       1. Oral
       2. Parenteral
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Oncology Centers
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. AstraZeneca Plc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Bristol-Myers Squibb Company
       3. F. Hoffmann-La Roche Ltd.
       4. Merck & Co., Inc.
       5. Novartis AG
       6. Pfizer Inc.
       7. Sanofi
       8. Eli Lilly and Company
       9. Teva Pharmaceuticals
       10. Boehringer Ingelheim GmbH
       11. Mylan N.V.
       12. Fresenius Kabi AG
       13. Sun Pharmaceuticals Industries Ltd
       14. Corden Pharma International GmbH
       15. Concordia International Corp
       16. Kyowa Hakko Kirin Co Ltd.
       17. Polaris Pharmaceuticals, Inc.
       18. MolMed SpA
       19. Ono Pharmaceutical Co. Ltd
       20. Nichi-Iko Pharmaceutical Co., Ltd
       21. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations